Target intelligence / Profile preview

Tumor necrosis factor ligand superfamily member 15 (TNFSF15)

Target
TNFSF15
Molecular classification
Cytokine, Tumor necrosis factor superfamily, Ligand
01

Overview

Tumor necrosis factor ligand superfamily member 15 (TNFSF15), commonly known as tumor necrosis factor-like ligand 1A (TL1A), is a proinflammatory cytokine belonging to the tumor necrosis factor (TNF) superfamily. It exists in both membrane-bound and soluble forms and is primarily expressed by endothelial cells, macrophages, dendritic cells, and activated lymphocytes in response to inflammatory stimuli. TL1A acts as a ligand that binds to death receptor 3 (DR3) on effector T cells, innate lymphoid cells, and fibroblasts, initiating downstream NF-κB and MAPK signaling pathways. This interaction co-stimulates T-cell activation, enhances the production of proinflammatory cytokines (such as IFN-γ, IL-17, and IL-22), and promotes tissue remodeling and collagen deposition.

Dysregulation and overexpression of TL1A are strongly implicated in the pathogenesis of chronic inflammatory and autoimmune diseases, most notably inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, as well as rheumatoid arthritis, psoriasis, and systemic sclerosis. Genetic polymorphisms in the TNFSF15 gene are highly correlated with susceptibility to and severity of IBD. Consequently, TL1A has emerged as a major therapeutic target, with several monoclonal antibodies—such as tulisokibart, afimkibart, and duvakitug—undergoing clinical development. These therapeutic agents neutralize TL1A to block the TL1A-DR3 signaling axis, thereby simultaneously suppressing mucosal inflammation and halting or reversing tissue fibrosis, offering a novel dual-action approach to treating refractory autoimmune disorders.

Other names
Tumor necrosis factor-like ligand 1ATL1AVascular endothelial growth inhibitorVEGITNF ligand-related molecule 1
02

Mechanism of action

Monoclonal antibody-mediated neutralization of soluble and membrane-bound TL1A, preventing its binding to death receptor 3 (DR3) and decoy receptor 3 (DcR3), thereby inhibiting downstream NF-κB and MAPK signaling pathways to suppress inflammation and fibrosis.

03

Biological functions

Immune responseInflammatory responseCell proliferationApoptosisAngiogenesis inhibitionFibrogenesis
04

Disease associations

Inflammatory bowel diseaseCrohn's diseaseUlcerative colitisRheumatoid arthritisPsoriasisPsoriatic arthritisAnkylosing spondylitisSystemic sclerosisHidradenitis suppurativaCancer
05

Safety considerations

Immunogenicity (anti-drug antibody formation due to immune complexes)Infection riskExacerbation of inflammatory bowel diseaseArthralgiaNasopharyngitis
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

TNFSF15 risk-variant genotypeSerum TL1A levelsMucosal TL1A expressionTh17 signature cytokines (IL-17, IL-22)

Beyond the preview

Go deeper on Tumor necrosis factor ligand superfamily member 15 (TNFSF15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor necrosis factor ligand superfamily member 15 (TNFSF15).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call